MMJ PhytoTech (ASX: MMJ)


MMJ PhytoTech (ASX: MMJ) is a medical cannabis company, aiming to commercialise medical cannabis and cannabis-based therapeutics. www.mmjphytotech.com.au

Cannabis Access Clinics Australia medical research price analysis

Cannabis Access Clinics looks to aid Australian patient access to medical cannabis

The theory behind medical cannabis is that it has the potential to soothe many of today’s ailments, with illnesses such as epilepsy, multiple sc...
MMJ ASX phase 2 clinical trial CBD impact epilepsy cannabis PhytoTech Therapeutics

MMJ’s phase 2 clinical trial shows CBD impact on epilepsy

Biotech and global cannabis investment company MMJ (ASX: MMJ) has published results from its phase 2 clinical trial, completed through its subsi...
MMJ ASX recreational cannabis deal Harvest One Canada

MMJ announces timely recreational cannabis deal through Harvest One in Canada

MMJ (ASX: MMJ) has pleased its shareholders this morning by announcing that subsidiary cannabis company Harvest One had signed an MoU with the B...
MMJ ASX Bien Ventures cannabis edibles market

MMJ snaps up early taste of cannabis edibles market

The blooming medical cannabis market has precipitated a series of acquisitions for MMJ (ASX: MMJ), the ASX-listed biotech company that is wheeli...
MMJ ASX MMJ medical cannabis research start-up Martha Jane Medical Ltd

MMJ collars first Australian medical cannabis investment in start-up Martha Jane Medical

MMJ (ASX: MMJ) has grown its exposure to the medical cannabis sector after securing its first Australian medical cannabis investment via a 12.6%...
Australian pot stocks cannabis Canada Creso Pharma MMJ CPH ASX

Australian pot stocks cultivating commercial progress in Canada

The onset of softening legislation towards cannabis in Canada and in other jurisdictions such as the US and Australia – both medicinally and rec...
MMJ PhytoTech ASX medical cannabis access

MMJ PhytoTech puts money into securing tomorrow’s medical cannabis customers

As a sure sign of the softening stance towards cannabis in Australia, especially its medicinal branch, MMJ PhytoTech (ASX: MMJ) has pulled the t...
United Greeneries MMJ ASX Harvest One cannabis production

MMJ reports 250% planned cannabis flower production increase by 2019

Pot stock investor MMJ PhytoTech (ASX: MMJ) reported its subsidiary Harvest One (TSX-V: HVST) plans to boost its cannabis flower production 250%...
MMJ Phytotech ASX MMJ Satipharm CBD epilepsy trial Phase 2

MMJ PhytoTech reports early results in Phase 2 epilepsy trial

The reintroduction of medical cannabis into treating illness and disease has received a boost, courtesy of clinical trials being conducted by MM...
MMJ PhytoTech ASX Canadian pot company cannabis Dosecann

MMJ secures stake in another Canadian pot company

MMJ PhytoTech (ASX: MMJ) has made another strategic investment in a Canadian pot company – this time, in Dosecann, which has a 45,000 square foo...
MMJ PhytoTech ASX MMJ Canada cannabis producer Weed Me

MMJ PhytoTech hooks stake in Canadian cannabis producer Weed Me

Medicinal cannabis company MMJ PhytoTech (ASX: MMJ) has corralled a stake in Ontario-based Weed Me, securing MMJ’s position in Canada’s expandin...
MMJ PhytoTech Australia Germany medicinal cannabis CBD

MMJ PhytoTech gets nod from Australian and German authorities

Emerging medicinal cannabis producer MMJ PhytoTech (ASX: MMJ) announced its 59%-owned subsidiary Satipharm AG has received regulatory approval t...
Medicinal cannabis MMJ PhytoTech TSX-V listing approval

Medicinal cannabis company MMJ PhytoTech receives conditional TSX-V listing approval

MMJ PhytoTech Limited (ASX: MMJ) has advised that Harvest One Capital Inc. (NEX: WON.H) has received conditional approval from the TSX Venture E...
MMJ cannabis crop harvest Duncan Facility

First cannabis crop harvested at MMJ’s Duncan Facility

MMJ PhytoTech Limited (ASX: MMJ) has advised the market that its wholly-owned subsidiary United Greeneries Holdings Ltd (UG) has successfully co...